A growing number of studies have shown that the release of inflammatory cytokines is an essential characteristic of lung parenchyma injury [26], and various inflammatory mediators, including IL-1s, TNF-α, and IL-6, are increased both in the BALF and circulating plasma of ARDS patients [32,33]. This evidence concerns the gene TNF and acute respiratory distress syndrome.